帕金森病患者与非帕金森病患者全髋关节置换术的匹配队列分析:并发症、死亡率、住院时间与住院费用
基于美国全国住院患者样本2000-2014年数据,将4003例合并帕金森病的全髋关节置换术患者按1:3匹配非帕金森病对照,分析并发症、死亡率、住院时间和费用;匹配队列中帕金森病与住院时间、总住院费用和院内并发症率增加相关,院内死亡率无差异。
要点
- 匹配队列中帕金森病患者住院时间3.1天 vs 对照2.7天,P < .001。
- 匹配队列中帕金森病患者总住院费用49,061美元 vs 对照45,571美元,P < .001。
- 匹配队列中帕金森病患者院内并发症率14.6% vs 对照11.7%,P < .001;院内死亡率0.50% vs 0.47%,P = .781。
核心结论
- 匹配队列分析显示,帕金森病患者全髋关节置换术后并发症率、住院时间和住院费用增加,但院内死亡率未增加。
- 作者指出,每例费用增加3490美元,在不断演变的「捆绑支付」模式下考虑帕金森病患者手术时可能值得关注。
研究设计与样本
- 研究评估了医疗成本与利用项目全国住院患者样本2000-2014年数据。
- 帕金森病患者按年龄、性别、Charlson合并症指数和入院年份以1:3比例倾向性评分匹配非帕金森病对照。
- 采用单变量和多变量逻辑回归分析匹配队列中帕金森病与手术结局的关系。
- 证据等级为预后性III级。
主要发现
- 2000-2014年共实施794,689例全髋关节置换术,其中4003例(0.50%)合并帕金森病。
- 匹配前,帕金森病关节置换患者年龄显著更大(P < .001)、男性更常见(P < .001)、Charlson合并症指数更高(P < .001)。
- 匹配队列中,帕金森病与住院时间增加相关(3.1 vs 2.7天,P < .001)。
- 匹配队列中,帕金森病与总住院费用增加相关(49,061 vs 45,571美元,P < .001)。
- 匹配队列中,帕金森病与院内并发症率增加相关(14.6% vs 11.7%,P < .001);院内死亡率无差异(0.50% vs 0.47%,P = .781)。
临床怎么用
- 作者指出,每例费用增加3490美元,在「捆绑支付」模式下考虑帕金森病患者手术时可能值得关注。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Increased complication rate has been reported in Parkinson's disease (PD) patients following total hip arthroplasty (THA). However, this has not previously been studied on a national scale. The purpose of this study was to determine whether PD patients had increased cost, complication, mortality, and length of stay following THA using a national database. METHODS: The Healthcare Cost and Utilization Project Nationwide Inpatient Sample was evaluated for the years 2000-2014. PD patients were matched 1:3 with non-PD control patients for age, gender, Charlson Comorbidity Index, and year of admission using a propensity score matching procedure. Univariable and multivariable logistic regression were used to determine the relationship between PD and surgical outcomes in the matched cohort. RESULTS: 794,689 THAs were performed from 2000-2014. 4003 patients (0.50%) had comorbid Parkinson's disease. Before matching, arthroplasty patients with PD were significantly older (P < .001), more frequently male (P < .001), and had greater Charlson Comorbidity Index (P < .001). In the matched cohort, PD was associated with increased length of stay (3.1 vs 2.7 days, P < .001), total hospital charges ($49,061 vs $45,571, P < .001), and in-hospital complication rate (14.6% vs 11.7%, P < .001). There was no difference in-hospital mortality (0.50% vs 0.47%, P = .781). CONCLUSIONS: Matched cohort analysis demonstrated increases in complication rate, length, and cost of hospitalization for THA in patients with PD. However, in-hospital mortality rate in PD patients was not increased. Of note, the elevation in per-episode cost ($3490) may be of concern when considering PD patients for surgery within the evolving "bundled payment" model of care. LEVEL OF EVIDENCE: Prognostic- Level III.
引用
- Kleiner JE, Eltorai AEM, Rubin LE, et al. Matched Cohort Analysis of Total Hip Arthroplasty in Patients With and Without Parkinson's Disease: Complications, Mortality, Length of Stay, and Hospital Charges. J Arthroplasty. 2019. PMID: 30982760. doi:10.1016/j.arth.2019.03.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。